Pet health market: progressing at a fast pace
The global pet care market is constantly growing
The growth drivers
Sales share shifting in favour of pet health products5
Pets’ longevity is enhanced by:
- human-like healthcare
- a better diet/shift to premium food
- more frequent vet visits/routine check-ups, driving the growth of vet services market...
… with more pet parents inclined to increase their vet expenses
According to our GRASSROOTS RESEARCH® findings for the US,8 69% of pet owners would increase their veterinarian expenses if it were necessary to extend their pet's life.
Rising implementation of digital diagnostics:
faster and more efficient clinical decision-making;
holistic view of diagnostics for a more accurate interpretation of results and determination of next steps
With increasing longevity of pets, the demand for drugs, vaccines and supplements that address special nutritional needs and preventive care requirements of (senior/geriatric) pets is rising.
The economic effects of changing pet medication
Global evolution of pet ownership and the rising medicalisation of pets9
Room for improvement opens up investment opportunities
Implications for investors
Lower development costs and shorter development times for vaccines:
- Increasing understanding by pet parents that vaccines are important for maintaining animal health, and to prevent zoonoses transfers from pets (rabies is estimated to cause 59,000 human deaths annually in over 150 countries12)
Transition from treating pet diseases to preventing them could drive the growth of preventive care and the digitalisation of clinical treatments
1 APPA, 2022.
2 Global Market Insights, November 2022.
3 China’s Pet Industry, PWC China, 2022 Update.
4 Global Market Insights: Veterinary Services Market, June 2022.
5 HealthforAnimals: Global State of Pet Care, July 2022.
6 Science.org: A dog that lives 300 years? Solving the mysteries of aging in our pets. December, 2015.
7 Global Market Insights: Veterinary Services Market, June 2022.
8 Survey of pet owners in the US 2018.
9 Credit Suisse, October 2018.
10 National Library of Medicine: Familiarity and Use of Veterinary Services by US Resident Dog and Cat Owners. March, 2020.
11 2021 PDSA Animal Wellbeing (PAW) Report. May, 2021.
12 World Health Organization.
Investing involves risk. The value of an investment and the income from it will fluctuate and investors may not get back the principal invested. Past performance is not indicative of future performance. This is a marketing communication. It is for informational purposes only. This document does not constitute investment advice or a recommendation to buy, sell or hold any security and shall not be deemed an offer to sell or a solicitation of an offer to buy any security. The views and opinions expressed herein, which are subject to change without notice, are those of the issuer or its affiliated companies at the time of publication. Certain data used are derived from various sources believed to be reliable, but the accuracy or completeness of the data is not guaranteed and no liability is assumed for any direct or consequential losses arising from their use. The duplication, publication, extraction or transmission of the contents, irrespective of the form, is not permitted. This material has not been reviewed by any regulatory authorities. In mainland China, it is for Qualified Domestic Institutional Investors scheme pursuant to applicable rules and regulations and is for information purpose only. This document does not constitute a public offer by virtue of Act Number 26.831 of the Argentine Republic and General Resolution No. 622/2013 of the NSC. This communication's sole purpose is to inform and does not under any circumstance constitute promotion or publicity of Allianz Global Investors products and/or services in Colombia or to Colombian residents pursuant to part 4 of Decree 2555 of 2010. This communication does not in any way aim to directly or indirectly initiate the purchase of a product or the provision of a service offered by Allianz Global Investors. Via reception of his document, each resident in Colombia acknowledges and accepts to have contacted Allianz Global Investors via their own initiative and that the communication under no circumstances does not arise from any promotional or marketing activities carried out by Allianz Global Investors. Colombian residents accept that accessing any type of social network page of Allianz Global Investors is done under their own responsibility and initiative and are aware that they may access specific information on the products and services of Allianz Global Investors. This communication is strictly private and confidential and may not be reproduced. This communication does not constitute a public offer of securities in Colombia pursuant to the public offer regulation set forth in Decree 2555 of 2010. This communication and the information provided herein should not be considered a solicitation or an offer by Allianz Global Investors or its affiliates to provide any financial products in Brazil, Panama, Peru, and Uruguay. In Australia, this material is presented by Allianz Global Investors Asia Pacific Limited (“AllianzGI AP”) and is intended for the use of investment consultants and other institutional/professional investors only, and is not directed to the public or individual retail investors. AllianzGI AP is not licensed to provide financial services to retail clients in Australia. AllianzGI AP is exempt from the requirement to hold an Australian Foreign Financial Service License under the Corporations Act 2001 (Cth) pursuant to ASIC Class Order (CO 03/1103) with respect to the provision of financial services to wholesale clients only. AllianzGI AP is licensed and regulated by Hong Kong Securities and Futures Commission under Hong Kong laws, which differ from Australian laws. This document is being distributed by the following Allianz Global Investors companies: Allianz Global Investors GmbH, an investment company in Germany, authorized by the German Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin); Allianz Global Investors (Schweiz) AG; in HK, by Allianz Global Investors Asia Pacific Ltd., licensed by the Hong Kong Securities and Futures Commission; ; in Singapore, by Allianz Global Investors Singapore Ltd., regulated by the Monetary Authority of Singapore [Company Registration No. 199907169Z]; in Japan, by Allianz Global Investors Japan Co., Ltd., registered in Japan as a Financial Instruments Business Operator [Registered No. The Director of Kanto Local Finance Bureau (Financial Instruments Business Operator), No. 424], Member of Japan Investment Advisers Association, the Investment Trust Association, Japan and Type II Financial Instruments Firms Association; in Taiwan, by Allianz Global Investors Taiwan Ltd., licensed by Financial Supervisory Commission in Taiwan; and in Indonesia, by PT. Allianz Global Investors Asset Management Indonesia licensed by Indonesia Financial Services Authority (OJK). 2705335